Inoue, M., Mlynash, M., Straka, M., Lansberg, M. G., Zaharchuk, G., Bammer, R., & Albers, G. W. (2012). Patients With the Malignant Profile Within 3 Hours of Symptom Onset Have Very Poor Outcomes After Intravenous Tissue-Type Plasminogen Activator Therapy.
Citação norma ChicagoInoue, Manabu, Michael Mlynash, Matus Straka, Maarten G. Lansberg, Greg Zaharchuk, Roland Bammer, and Gregory W. Albers. Patients With the Malignant Profile Within 3 Hours of Symptom Onset Have Very Poor Outcomes After Intravenous Tissue-Type Plasminogen Activator Therapy. 2012.
Citação norma MLAInoue, Manabu, et al. Patients With the Malignant Profile Within 3 Hours of Symptom Onset Have Very Poor Outcomes After Intravenous Tissue-Type Plasminogen Activator Therapy. 2012.